DNA damage response and hematological malignancy

Multidrug resistance in hematological malignancy.

The recent treatment of hematological malignancies appears to be unsatisfactory in child and adult patients with acute myeloid leukemia and adult patients with acute lymphocytic leukemia. A major problem in the treatment of leukemia is caused by the development of drug resistance to chemotherapeutic agents, which is already present at diagnosis or after chemotherapy as a minimal residual diseas...

DNA damage response and neuroprotection.

The protection of genomic integrity is a major challenge for living cells that are continuously exposed to endogenous and environmental DNA-damaging insults. To cope with the consequences of DNA lesions which interfere with essential DNA-dependent processes including transcription and replication, cells are equipped with an efficient defense mechanism termed the DNA damage response. Its functio...

Radiation track and DNA damage

DNA Damage Response Pathways

ownload B4 is unusual among receptor tyrosine kinases because some isoforms can be efficiently cleaved at the a membrane to release a soluble intracellular domain. The cleavage product has high kinase activity mes to the nucleus. A screen for proteins that associate with the ErbB4 intracellular domain identified ate interactors including ITCH, WWP2, Nucleolin, and Krab-associated protein 1 (Kap...

Oxidative DNA Damage and Pro-inflammatory Response In Chronic Exposure To Cement Dust